Sritharan Thulasi, Salim Angela A, Khalil Zeinab G, Capon Robert J
Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Antibiotics (Basel). 2024 Jan 18;13(1):97. doi: 10.3390/antibiotics13010097.
The Australian roadside soil-derived fungus CMB-STF067 was prioritized for chemical investigation based on an SDA cultivation extract exhibiting both antibacterial properties and natural products with unprecedented molecular formulae (GNPS). Subsequent miniaturized 24-well plate cultivation profiling (MATRIX) identified red rice as optimal for the production of the target chemistry, with scaled-up cultivation, extraction and fractionation yielding four new xanthone-anthraquinone heterodimers, jugiones A-D (-), whose structures were assigned by detailed spectroscopic analysis and biosynthetic considerations. Of note, where - and were active against the Gram-positive bacteria vancomycin-resistant (IC 2.6-3.9 μM) and multiple-drug-resistant clinical isolates of (IC 1.8-6.4 μM), and inactive against the Gram-negative bacteria (IC > 30 μM), the closely related analog exhibited no antibacterial properties (IC > 30 μM). Furthermore, where was cytotoxic to human carcinoma (IC 9.0-9.8 μM) and fungal (IC 4.1 μM) cells, and displayed no such cytotoxicity (IC > 30 μM), revealing an informative structure activity relationship (SAR). We also extended the SAR study to other known compounds of this heterodimer class, which showed that the modification of ring G can reduce or eliminate the cytotoxicity while retaining the antibacterial activity.
基于一种表现出抗菌特性且含有具有前所未有的分子式的天然产物(全球天然产物社会分子网络)的SDA培养提取物,澳大利亚路边土壤来源的真菌CMB - STF067被优先用于化学研究。随后的小型化24孔板培养分析(MATRIX)确定红米是生产目标化合物的最佳选择,通过放大培养、提取和分馏得到了四种新的呫吨酮 - 蒽醌杂二聚体,jugiones A - D(-),其结构通过详细的光谱分析和生物合成考虑得以确定。值得注意的是,其中jugiones A和B对革兰氏阳性耐万古霉素肠球菌(IC₅₀ 2.6 - 3.9 μM)和多重耐药临床分离株金黄色葡萄球菌(IC₅₀ 1.8 - 6.4 μM)有活性,而对革兰氏阴性菌大肠杆菌(IC₅₀ > 30 μM)无活性,与之密切相关的类似物jugiones C则没有抗菌特性(IC₅₀ > 30 μM)。此外,其中jugiones A对人癌细胞(IC₅₀ 9.0 - 9.8 μM)和真菌细胞(IC₅₀ 4.1 μM)具有细胞毒性,而jugiones B和C没有这种细胞毒性(IC₅₀ > 30 μM),揭示了一种有用的构效关系(SAR)。我们还将SAR研究扩展到了这类杂二聚体的其他已知化合物,结果表明对G环的修饰可以降低或消除细胞毒性,同时保留抗菌活性。